Organisation
Department of Pharmaceutics
Department
Current researchers
31 - 40 of 120 results
- Sarah De Keulenaer (Member)
- Emily De Lombaerde (Member)
- Ellen De Meester (Member)
- Kristien De Paepe (Member)
- Elisa De Pauw (Member)
- Stefaan De Smedt (Member)
- Margo De Velder (Member)
- Lotte De Wever (Member)
- Aliona Debisschop (Member)
- Ann Debunne (Member)
Projects
31 - 40 of 375
- Laser-induced nanobubbles for advanced therapies in the eyeFrom1 Sep 2023 → TodayFunding: BOF - projects
- Pulsed Laser Light and Nano-encapsulated Ocular Dyes for Advanced Therapies in the EyeFrom1 Sep 2023 → TodayFunding: Horizon Europe - European Research Council (ERC)
- Novel photosensitizers to push the limits of photodynamic cancer therapyFrom14 Aug 2023 → TodayFunding: IOF - technology concept exploration
- Increasing the value proposition of the IOF programs CRISParray and Amalus: CRISPRi-based target deconvolution of fibroblast modulatorsFrom15 Jul 2023 → TodayFunding: IOF - technology validation in lab
- Identification of optimized Aurora Kinase A PROTACs with suitable PK properties for in vivo proof-of-concept studies (OPTIMAPK).From15 Jul 2023 → TodayFunding: IOF - technology concept exploration
- Postdoctoral Fellowship Program in National Glaucoma Research: "“Exploring ICG-mediated ILM photodisruption as a tool to boost retinal ganglion cell engraftment"From1 Jul 2023 → TodayFunding: Foreign private sponsor - undefined
- Immunopeptidomics-based Development of Next-Generation Bacterial mRNA VaccinesFrom1 Jul 2023 → TodayFunding: HORIZON.2.1 - Health
- TARgeted Mrna re-engineering for enhanced Antibody and Cellular immunity (TARMAC)From15 Apr 2023 → 14 Apr 2024Funding: IOF - technology concept exploration
- New antivirals against human parainfluenza virusFrom1 Apr 2023 → TodayFunding: IOF - technology validation in lab
- A Belgian representation on the Scientific Advice Working Party (SAWP) of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).From1 Mar 2023 → TodayFunding: FOD Public Health, Safety of the food chain and the Environment
Publications
1 - 10 of 1925
- Synthesis and potency of novel uracil nucleotides and derivatives as P2Y(2) and P2Y(6) receptor agonists(2008)
Authors: HJ Ko, RL Carter, Liesbet Cosyn, R Petrelli, S de Castro, P Besada, YX Zhou, L Cappellacci, P Franchetti, M Grifantini, et al.
Pages: 6319 - 6332 - Human mitochondrial thymidine kinase is selectively inhibited by 3'-thiourea derivatives of beta-thymidine: identification of residues crucial for both inhibition and catalytic activity(2009)
Authors: Jan Balzarini, Ineke Van Daele, Ana Negri, Nicola Solaroli, Anna Karlsson, Sandra Liekens, Frederico Gago, Serge Van Calenbergh
Pages: 1127 - 1136 - ERS guidelines, statements and technical standards published in the ERJ in 2014: a year in review(2015)
Authors: Guy Brusselle, Mina Gaga
Pages: 863 - 866 - Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status(2012)
Authors: Guy Brusselle, Rudi Peché, Paul Van den Brande, Albert Verhulst, Wim Hollanders, Jacques Bruhwyler
Pages: 811 - 819 - Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns(2014)
Authors: David Price, Daniel West, Guy Brusselle, Kevin Gruffydd-Jones, Rupert Jones, Marc Miravitlles, Andrea Rossi, Catherine Hutton, Valerie L Ashton, Rebecca Stewart, et al.
Pages: 889 - 905 - Integrating real-life studies in the global therapeutic research framework(2013)
Authors: Nicolas Roche, Helen K Reddel, Alvar Agusti, Eric D Bateman, Jerry A Krishnan, Richard J Martin, Alberto Papi, Dirkje Postma, Mike Thomas, Guy Brusselle, et al.
Pages: e29 - e30 - The significance of eosinophilic inflammation in chronic obstructive pulmonary disease(2018)
Authors: Christopher B Cooper, Guy Brusselle, Steven J Pascoe, Ian D Pavord
Pages: 967 - 968 - InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients: the LIAISON study protocol(2013)
Authors: Fulvio Braido, Guy Brusselle, Eleonora Ingrassia, Gabriele Nicolini, David Price, Nicolas Roche, Joan B Soriano, Heinrich Worth
- Risk of a biased assessment of the evidence when limiting literature searches to the English language : macrolides in asthma as an illustrative example(2015)
Authors: Guy Brusselle, Francesco Blasi
Pages: 109 - 110 - Exacerbation rate reduction according to baseline blood eosinophilic count in patients with asthma treated with ICS/LABA maintenance and reliever therapy(2019)Volume: 199
Authors: Guy Brusselle, A Papi, G Nicolini, L Santoro, D Guastalla
Number of pages: 1